Greenwood, IN, United States of America

Lowell L Gibson

This inventor holds 5 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1989-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 112(Granted Patents)


Location History:

  • Beech Grove, IN (US) (1989 - 1992)
  • Greenwood, IN (US) (1998 - 1999)

Company Filing History:


Years Active: 1989-1999

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Lowell L Gibson

Introduction

Lowell L Gibson is a notable inventor based in Greenwood, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the delivery of raloxifene, a medication used primarily for the treatment of osteoporosis.

Latest Patents

Gibson holds 5 patents, with his latest inventions focusing on solid orally administerable pharmaceutical formulations. One of his key patents provides formulations comprising raloxifene, its ethers or esters, or a pharmaceutically-acceptable salt thereof, combined with a hydrophilic carrier composition. Another important patent details solid formulations that include raloxifene hydrochloride, a surfactant such as sorbitan fatty acid ester or a polyoxyethylene sorbitan fatty acid ester, polyvinylpyrrolidone, and a water-soluble diluent like polyol or sugar.

Career Highlights

Gibson has built a successful career at Eli Lilly and Company, where he has been instrumental in advancing pharmaceutical innovations. His work has contributed to the development of effective treatments that improve patient outcomes.

Collaborations

Throughout his career, Gibson has collaborated with esteemed colleagues, including Arvind L Thakkar and Kerry John Hartauer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Lowell L Gibson's contributions to pharmaceutical formulations demonstrate his commitment to improving healthcare through innovation. His patents reflect a deep understanding of drug delivery systems, which continue to benefit patients worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…